The team partners with companies looking for services that range from small-scale process development through to bulk commercial manufacturing.
AbbVie’s 110,000 ft2 Sligo location houses a state-of-the-art high containment facility and dedicated quality control labs. It is optimized for a wide range of potent pharmaceuticals, along with new product introduction (NPI) and development, along with regulatory experts on hand to help guide the process.
The Sligo facility is a dedicated cGMP plant for potent active pharmaceutical ingredients and potent drug products, and is IMB, EU and FDA approved for both large-scale commercial manufacture and clinical trial supplies. It is capable of handling the highest classifications of potent compounds – with containment levels up to OEB 5 (OEL <1 μg/m3), among the highest for pharmaceutical manufacturers in Ireland and globally.
